Evidence map›Paper›PMID 30268853›Full record

ArticleInternational journal of pharmaceutics2018

Controlled drug delivery from 3D printed two-photon polymerized poly(ethylene glycol) dimethacrylate devices.

Anh-Vu Do, Kristan S Worthington, Budd A Tucker, Aliasger K Salem

Abstract read
In one paragraph

Article in International journal of pharmaceutics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 62 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Two-Photon Polymerization: Fundamentals, Materials, and Chemical Modification Strategies.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2023
    Review
  10. Article
  11. Review
  12. Review
  13. Review
  14. Two-photon polymerization for 3D biomedical scaffolds: Overview and updates.Frontiers in bioengineering and biotechnology · 2022
    Review
  15. Article
  16. Review
  17. Article
  18. Review
  19. Applications of nanotechnology in 3D printed tissue engineering scaffolds.European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V · 2021
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Anh-Vu DoDivision of Pharmaceutics and Translational Therapeutics, College of Pharmacy, University of Iowa, United States; Department of Chemical and Biochemical Engineering, College of Engineering, The University of Iowa, United States.
Kristan S WorthingtonInstitute for Vision Research, Department of Ophthalmology and Visual Sciences, College of Medicine, The University of Iowa, United States; Department of Biomedical Engineering, College of Engineering, The University of Iowa, United States.
Budd A TuckerInstitute for Vision Research, Department of Ophthalmology and Visual Sciences, College of Medicine, The University of Iowa, United States.
Aliasger K SalemDivision of Pharmaceutics and Translational Therapeutics, College of Pharmacy, University of Iowa, United States; Department of Chemical and Biochemical Engineering, College of Engineering, The University of Iowa, United States; Department of Biomedical Engineering, College of Engineering, The University of Iowa, United States. Electronic address: aliasger-salem@uiowa.edu.
University of Iowa · US

Funding

Tumor Microenvironment and Cancer ImmunologyP30CA030199 · NCI · SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · PI Michael Jackson · 1985 to 2026
$107.2M
Viral VectorP30CA086862 · NCI · UNIVERSITY OF IOWA · PI Douglas Robert Spitz · 2000 to 2026
$70.0M
Choriocapillaris Protection and Replacement in AMDR01EY024605 · NEI · UNIVERSITY OF IOWA · PI Robert Foster Mullins, Budd A Tucker · 2014 to 2026
$4.6M
Nanovaccine platforms to combat pancreatic cancerU01CA213862 · NCI · IOWA STATE UNIVERSITY · PI JAIN, MANEESH, NARASIMHAN, BALAJI · 2017 to 2021
$2.7M
Development of a cell replacement therapy to treat retinal degenerative blindnessDP2OD007483 · OD · UNIVERSITY OF IOWA · PI TUCKER, BUDD A · 2010 to 2010
$2.3M
CRISPR/Cas9-mediated correction of mutations that cause inherited retinal degenerationsR01EY026008 · NEI · UNIVERSITY OF IOWA · PI STONE, EDWIN M, TUCKER, BUDD A · 2016 to 2022
$2.2M
Disease Mechanisms in Best DiseaseR01EY024588 · NEI · UNIVERSITY OF IOWA · PI GAMM, DAVID M, MULLINS, ROBERT FOSTER · 2015 to 2018
$2.0M
FUNDS TO ACQUIRE A JEOL JSM-7401F FESEM: LUNGS10RR022498 · NCRR · UNIVERSITY OF IOWA · PI APICELLA, MICHAEL A. · 2006 to 2006
$445k
NCI NIH HHS P30 CA086862NCI NIH HHS U01 CA213862NCRR NIH HHS S10 RR022498NEI NIH HHS R01 EY024588NEI NIH HHS R01 EY024605NEI NIH HHS R01 EY026008NIH HHS DP2 OD007483
6 · The paper itself

Abstract

Controlled drug delivery systems have been utilized to enhance the therapeutic effects of many drugs by delivering drugs in a time-dependent and sustained manner. Here, with the aid of 3D printing technology, drug delivery devices were fabricated and tested using a model drug (fluorophore: rhodamine B). Poly(ethylene glycol) dimethacrylate (PEGDMA) devices were fabricated using a two-photon polymerization (TPP) system and rhodamine B was homogenously entrapped inside the polymer matrix during photopolymerization. These devices were printed with varying porosity and morphology using varying printing parameters such as slicing and hatching distance. The effects of these variables on drug release kinetics were determined by evaluating device fluorescence over the course of one week. These PEGDMA-based structures were then investigated for toxicity and biocompatibility in vitro, where MTS assays were performed using a range of cell types including induced pluripotent stem cells (iPSCs). Overall, tuning the hatching distance, slicing distance, and pore size of the fabricated devices modulated the rhodamine B release profile, in each case presumably due to resulting changes in the motility of the small molecule and its access to structure edges. In general, increased spacing provided higher drug release while smaller spacing resulted in some occlusion, preventing media infiltration and thus resulting in reduced fluorophore release. The devices had no cytotoxic effects on human embryonic kidney cells (HEK293), bone marrow stromal stem cells (BMSCs) or iPSCs. Thus, we have demonstrated the utility of two-photon polymerization to create biocompatible, complex miniature devices with fine details and tunable release of a model drug.

Indexed as

Drug Delivery SystemsPrinting, Three-DimensionalDrug LiberationFluorescent DyesHEK293 CellsHumansInduced Pluripotent Stem CellsMesenchymal Stem CellsMethacrylatesPolyethylene GlycolsPolymerizationRhodaminesFluorescent DyesMethacrylatespoly(ethylene glycol)-dimethacrylatePolyethylene Glycolsrhodamine BRhodamines3D printingControlled drug releasePEGDMATwo-photon polymerization

Identifiers

PMID30268853
PMCPMC6204107
OpenAlexW2892789244

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.